These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25821160)

  • 1. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.
    Li R; Li H; Yan W; Yang P; Bao Z; Zhang C; Jiang T; You Y
    Oncotarget; 2015 Mar; 6(9):7318-24. PubMed ID: 25821160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor.
    Gessler F; Zappi J; Konczalla J; Bernstock JD; Forster MT; Wagner M; Mittelbronn M; Seifert V; Senft C
    World Neurosurg; 2017 Jun; 102():49-55. PubMed ID: 28263929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
    Li R; Chen X; You Y; Wang X; Liu Y; Hu Q; Yan W
    Oncotarget; 2015 Oct; 6(31):30968-74. PubMed ID: 26427041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.
    Kalkan R; Atli Eİ; Özdemir M; Çiftçi E; Aydin HE; Artan S; Arslantaş A
    Gene; 2015 Jan; 554(1):81-6. PubMed ID: 25455102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype.
    Yan W; Liu Y; Yang P; Wang Z; You Y; Jiang T
    Oncotarget; 2015 May; 6(13):11676-82. PubMed ID: 25869098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomas.
    Hill VK; Shinawi T; Ricketts CJ; Krex D; Schackert G; Bauer J; Wei W; Cruickshank G; Maher ER; Latif F
    BMC Cancer; 2014 Jul; 14():506. PubMed ID: 25012071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: a report of 118 patients from China.
    Yan W; Zhang W; You G; Bao Z; Wang Y; Liu Y; Kang C; You Y; Wang L; Jiang T
    PLoS One; 2012; 7(1):e30339. PubMed ID: 22291938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype.
    Wang HY; Li JY; Liu X; Yan XY; Wang W; Wu F; Liang TY; Yang F; Hu HM; Mao HX; Liu YW; Zhang SZ
    Oncotarget; 2016 Nov; 7(46):74895-74903. PubMed ID: 27713134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
    Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
    J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isocitrate dehydrogenase-1 mutations as prognostic biomarker in glioblastoma multiforme patients in West Bohemia.
    Polivka J; Polivka J; Rohan V; Pesta M; Repik T; Pitule P; Topolcan O
    Biomed Res Int; 2014; 2014():735659. PubMed ID: 24511544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma.
    Hu JL; Luo WJ; Wang H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819846636. PubMed ID: 31072237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.
    Murnyák B; Kouhsari MC; Hershkovitch R; Kálmán B; Marko-Varga G; Klekner Á; Hortobágyi T
    Oncotarget; 2017 Jul; 8(28):46348-46362. PubMed ID: 28654422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
    Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
    Nobusawa S; Watanabe T; Kleihues P; Ohgaki H
    Clin Cancer Res; 2009 Oct; 15(19):6002-7. PubMed ID: 19755387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
    Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
    EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients.
    Wang K; Wang Y; Fan X; Wang J; Li G; Ma J; Ma J; Jiang T; Dai J
    Neuro Oncol; 2016 Apr; 18(4):589-97. PubMed ID: 26409566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas.
    Ohno M; Narita Y; Miyakita Y; Matsushita Y; Yoshida A; Fukushima S; Ichimura K; Shibui S
    Brain Tumor Pathol; 2013 Oct; 30(4):224-32. PubMed ID: 23494632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TERT promoter mutations in primary and secondary glioblastomas.
    Nonoguchi N; Ohta T; Oh JE; Kim YH; Kleihues P; Ohgaki H
    Acta Neuropathol; 2013 Dec; 126(6):931-7. PubMed ID: 23955565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a DNA Repair-Related Multigene Signature as a Novel Prognostic Predictor of Glioblastoma.
    Jin S; Qian Z; Liang T; Liang J; Yang F; Sun L; Li W; Qiu X; Zhang M
    World Neurosurg; 2018 Sep; 117():e34-e41. PubMed ID: 29807183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.